← Back to Search

Sleep and Circadian Interventions for High Blood Pressure

N/A
Recruiting
Led By Saurabh S Thosar, PhD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 25-64
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-2 nights
Awards & highlights

Study Summary

This trial looks at how sleep and the body's natural 24-hour clock affects blood pressure in people with hypertension.

Who is the study for?
This trial is for adults aged 25-64 with a BMI of 18.5-42kg/m2 and hypertension, having an average resting BP between 130/80 mmHg and 160/100 mmHg. Excluded are heavy smokers, recent shift workers, frequent travelers across time zones, those on certain meds or with drug/alcohol issues, pregnant women, individuals with severe cardiovascular or psychological conditions, and those with serious sleep disorders.Check my eligibility
What is being tested?
The study examines how the body's circadian rhythm (24-hour cycle) and sleep quality affect blood pressure in hypertensive patients. Participants will undergo various trials including a Circadian Protocol to assess their natural rhythms, Overnight Sleep Trial monitored by polysomnography at home to evaluate sleep patterns, Rested Wakefulness Trial to observe alertness levels after restful sleep, and adherence to a Regularized Sleep Schedule.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring rather than medication or invasive procedures, side effects are minimal but may include discomfort from wearing monitoring equipment during sleep studies or potential disruption of normal sleeping patterns due to the regularized schedule.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 25 and 64 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-2 nights
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-2 nights for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Aldosterone (Circadian and Overnight sleep vs. rested wakefulness trial)
Blood pressure (Circadian and Overnight sleep vs. rested wakefulness trial)
Epinephrine (Circadian and Overnight sleep vs. rested wakefulness trial)
+9 more
Secondary outcome measures
Ambulatory blood pressure (Sleep regularization trial)
Blood pressure dipping status (Sleep regularization trial)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dipping vs non-dipping HTNExperimental Treatment5 Interventions
Participants will wear an ambulatory blood pressure monitor (SpaceLabs, Inc.) which will take their blood pressure in 20-30-minute intervals for 24-48 hours to determine blood pressure dipping status. All participants in this arm will complete the experiments in this order: At-home polysomnography; Constant Routine protocol; Rested Wakefulness Trial AND Overnight Sleep Trial (Randomized crossover); Sleep Regularization Trial

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
974 Previous Clinical Trials
7,385,880 Total Patients Enrolled
Saurabh S Thosar, PhDPrincipal InvestigatorOregon Health and Science University
2 Previous Clinical Trials
122 Total Patients Enrolled

Media Library

Regularized Sleep Schedule Clinical Trial Eligibility Overview. Trial Name: NCT05184933 — N/A
High Blood Pressure Research Study Groups: Dipping vs non-dipping HTN
High Blood Pressure Clinical Trial 2023: Regularized Sleep Schedule Highlights & Side Effects. Trial Name: NCT05184933 — N/A
Regularized Sleep Schedule 2023 Treatment Timeline for Medical Study. Trial Name: NCT05184933 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this study require participants to be adults?

"As per the inclusion criteria listed on the study, patients that can enroll are aged 25 to 64. There are 115 other trials for patients younger than 25 and 1168 for seniors."

Answered by AI

Are recruitment efforts still underway for this experiment?

"Indeed, the clinical trial is currently looking for participants, as shown by the data on clinicaltrials.gov. This study was originally posted on 6/1/2022 and edited on 9/26/2022. 1 centre is looking for 32 individuals to take part in this experiment."

Answered by AI

How many men and women are currently enrolled in this trial?

"The data available on clinicaltrials.gov show that this study is currently looking for patients to enroll. This trial was first posted on June 1st, 2022 and was most recently updated on September 26th, 2022. A total of 32 patients are needed at 1 trial site."

Answered by AI
~20 spots leftby Mar 2027